About Onkos Surgical
Onkos Surgical is a company based in Parsippany Troy Hills (United States) founded in 2015 by Patrick Treacy and Antony Koblish. Onkos Surgical has raised $72.33 million across 5 funding rounds from investors including 3D Systems, Canaan and Horizon Tech Finance. Onkos Surgical operates in a competitive market with competitors including Stryker, Zimmer Biomet, Smith & Nephew, NuVasive and CARLSMED, among others.
- Headquarter Parsippany Troy Hills, United States
- Founders Patrick Treacy, Antony Koblish
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$72.33 M (USD)
in 5 rounds
-
Latest Funding Round
$35 M (USD), Debt – Conventional
Jan 08, 2025
-
Investors
3D Systems
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Onkos Surgical
Unlock access to complete
Unlock access to complete
Funding Insights of Onkos Surgical
Onkos Surgical has successfully raised a total of $72.33M across 5 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $35 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Onkos Surgical
Onkos Surgical has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include 3D Systems, Canaan and Horizon Tech Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Structured debt is provided to life sciences and technology firms.
|
Locked | Locked | Locked | |
|
Expansion and growth capital is provided by 1315 Capital to healthcare companies.
|
Locked | Locked | Locked | |
|
Canaan is recognized as an early-stage venture capital firm.
|
Locked | Locked | Locked |
Investor details for Onkos Surgical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Onkos Surgical
Investment portfolio details for Onkos Surgical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Onkos Surgical
Detailed financials for Onkos Surgical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Onkos Surgical Comparisons
Peer comparison for Onkos Surgical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Onkos Surgical
Onkos Surgical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Stryker, Zimmer Biomet, Smith & Nephew, NuVasive and CARLSMED, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
3D-printed orthopedic products are manufactured for medical applications.
|
|
| Locked | Locked | Locked |
Medical devices for multiple health purposes are manufactured.
|
|
| Locked | Locked | Locked |
Manufacturer of knee, hip and shoulder joint replacements
|
|
| Locked | Locked | Locked |
Smart surgical devices for spinal surgery are developed.
|
|
| Locked | Locked | Locked |
Developer of devices for spine surgery
|
|
| Locked | Locked | Locked |
Surgical instruments for orthopaedics are developed and manufactured.
|
Detailed competitors of Onkos Surgical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Onkos Surgical
Complete news archive for Onkos Surgical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Onkos Surgical
Onkos Surgical was founded in 2015.
Onkos Surgical is headquartered in Parsippany Troy Hills, United States. It is registered at Parsippany Troy Hills, New Jersey, United States.
Patrick Treacy is the current CEO of Onkos Surgical. They have also founded this company.
Onkos Surgical is a funded company, having raised a total of $72.33M across 5 funding rounds to date.
Onkos Surgical is focused on developing implants and instruments for musculoskeletal tumor patients. The Guardian Limb Salvage System is designed to provide options for patients when a surgical intervention is required due to cancer or metastatic diseases. The system is indicated for procedures when a radical resection and replacement of the proximal tibia andor proximal, distal andor total femur is required. They use 3D technology to develop modular systems patient specific products. Its solutions include the GUARDIAN Limb Salvage System which includes hinges for the femur and tibia for indications during surgical intervention. It has partnered with Vivex Biomedical to provide a portfolio of tissue products to support the needs of musculoskeletal oncologists. The companys uDesign Patient Solutions is a combination of advanced 3D printing technologies, limb restoration technologies, and biologic solutions.
Onkos Surgical has 4 investors. Key investors include 3D Systems, Canaan, Horizon Tech Finance, and 1315 Capital.